Comparison of Image Quality Between Ultra-low Dose (ULD) and Standard Dose CT Scans in Detecting Traumatic Brain Injury in the Emergency Room
ULD-CRANE 2
1 other identifier
interventional
77
1 country
1
Brief Summary
Head trauma is a frequent reason for consultation in the emergency room. The CT scan is the reference examination allowing rapid management of the patient. However, CT examinations are among the diagnostic examinations with the highest exposure to ionizing radiation. The study investigators have previously implemented "ultra-low dose" (ULD) acquisitions for several pathologies with an effective dose level similar to that of a standard radiographic examination. These ULD acquisitions are now routinely used in our clinical practice for explorations of the thorax, spine, pelvis and proximal femurs, extremities. This study expands these ULD acquisitions to skull CT for detecting traumatic intracranial lesions. The study investigators hypothesize that it would be possible to search for intracranial lesions in patients with head trauma using ULD protocols, thereby reducing the doses delivered to the patient while maintaining sufficient image quality for the diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2022
CompletedFirst Posted
Study publicly available on registry
January 27, 2022
CompletedStudy Start
First participant enrolled
May 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 19, 2023
CompletedMarch 10, 2025
March 1, 2025
1.4 years
January 14, 2022
March 7, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Image quality of ultra-low dose scan compared to classic dose for visualising the differentiation of grey/white matter
5-point scale: unacceptable, sub-optimal, acceptable, better than average
Day 0
Image quality of ultra-low dose scan compared to classic dose for visualising lenticular nuclei
5-point scale: unacceptable, sub-optimal, acceptable, better than average
Day 0
Image quality of ultra-low dose scan compared to classic dose for visualising the ventricular system
5-point scale: unacceptable, sub-optimal, acceptable, better than average
Day 0
Image quality of ultra-low dose scan compared to classic dose for visualising basal cisterns
5-point scale: unacceptable, sub-optimal, acceptable, better than average
Day 0
Image quality of ultra-low dose scan compared to classic dose for visualising deconvexed subarachnoid spaces
5-point scale: unacceptable, sub-optimal, acceptable, better than average
Day 0
Secondary Outcomes (12)
Inter-evaluator concordance (senior versus junior) in visualizing all five structures (differentiation of grey/white matter, lenticular nuclei, ventricular system, basal cisterns, deconvexed subarachnoid spaces)
Day 0
Presence of at least one extradural hematoma by ultra-low dose versus classical scanner
Day 0
Presence of at least one subarachnoid hemorrhage by ultra-low dose versus classical scanner
Day 0
Presence of at least one subdural hematoma by ultra-low dose versus classical scanner
Day 0
Presence of at least one intraparenchymal hemorrhage by ultra-low dose versus classical scanner
Day 0
- +7 more secondary outcomes
Study Arms (1)
Patients with head trauma
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Patient presenting to the emergency room of the CHU of Nîmes for a cranial trauma requiring scanning.
- Patient with isolated head injury or polytrauma patient with head injury among others.
- The patient or their legal representative or family member must have given their free and informed consent and signed the consent form, or the patient was included under an emergency situation
- The patient must be a member or beneficiary of a health insurance plan
You may not qualify if:
- Patient is pregnant, parturient or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nimes
Nîmes, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicolas Menjot de Champfleur
CHU Nimes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2022
First Posted
January 27, 2022
Study Start
May 12, 2022
Primary Completion
October 19, 2023
Study Completion
October 19, 2023
Last Updated
March 10, 2025
Record last verified: 2025-03